Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

The gel with special fat-loaded particles from rice bran could be an effective skin treatment for hair loss.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Sargassum muticum extract and its component apo-9'-fucoxanthinone may help hair growth and treat hair loss.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Caffeine can boost health but may cause side effects like high blood pressure and migraines.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Compounds from the plant Mammea siamensis may help treat hair loss.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Animal models are crucial for learning about hair loss and finding treatments.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

A new method was developed to accurately measure enzyme activity related to prostate health.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.